T, K., T, Y., K, B., E, L., MV, D., M, M., . . . SF, S. (2023). Low-dose or -number of BCG in non-muscle invasive bladder cancer: Updated systematic review and meta-analysis. Immunotherapy, 15(12), 933. https://doi.org/10.2217/imt-2022-0309
Chicago Style (17th ed.) CitationT, Kawada, et al. "Low-dose or -number of BCG in Non-muscle Invasive Bladder Cancer: Updated Systematic Review and Meta-analysis." Immunotherapy 15, no. 12 (2023): 933. https://doi.org/10.2217/imt-2022-0309.
MLA (9th ed.) CitationT, Kawada, et al. "Low-dose or -number of BCG in Non-muscle Invasive Bladder Cancer: Updated Systematic Review and Meta-analysis." Immunotherapy, vol. 15, no. 12, 2023, p. 933, https://doi.org/10.2217/imt-2022-0309.
Warning: These citations may not always be 100% accurate.